Glucovance

Glucovance Teaching 112

Instructed in new medication Glucovance to improve glycemic control in patients with type-two diabetes whose hyperglycemia cannot be controlled with diet and exercise alone. In addition, warned of possible S/E such as headache, dizziness, diarrhea, nausea, vomiting, abdominal pain, hypoglycemia, lactic acidosis, or upper respiratory tract infection. Instructed to take one daily with breakfast and, if twice daily, then at breakfast and dinner. Stop drug and tell prescriber of unexplained hyperventilation, myalgia, malaise, unusual somnolence, or other symptoms of early lactic acidosis. GI symptoms are common with initial drug therapy but GI symptoms that occur after prolonged therapy may be related to lactic acidosis or other serious disease and should be reported promptly. Instructed not to take any other drugs, including OTC drugs, without checking with prescriber.